Serum vascular endothelial growth factors A, C and D in human breast tumors

Pathology and Oncology Research

Volumn 16, Issue 3, 2010, Pages 337-344

  Gisterek, Iwona ^a   Matkowski, Rafal ^a   Lacko, Aleksandra ^a   Sedlaczek, Pawel ^a   Szewczyk, Krzysztof ^a   Biecek, Przemyslaw ^c   Halon, Agnieszka ^a   Staszek, Urszula ^a   Szelachowska, Jolanta ^a   Pudelko, Marek ^b   Bebenek, Marek ^b   Harlozinska Szmyrka, Antonina ^a   Kornafel, Jan ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Wroclaw   (Poland)

^c UNIVERSITY OF WARSAW   (Poland)

Author keywords

Breast cancer; Serum assay; Vascular endothelial growth factor A; Vascular endothelial growth factor C; Vascular endothelial growth factor D

Indexed keywords

CYTOKINE; ESTROGEN RECEPTOR; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN D;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BENIGN TUMOR; BREAST CANCER; BREAST TUMOR; CANCER ADJUVANT THERAPY; CANCER PATIENT; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ERYTHROCYTE COUNT; FEMALE; HISTOPATHOLOGY; HUMAN; LEUKOCYTE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MASTECTOMY; PARTIAL MASTECTOMY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; THROMBOCYTE; THROMBOCYTE COUNT;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 77956873022     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-009-9211-8     Document Type: Article

References (25)

1. J Kinoshita K Kitamura A Kabashima H Saeki S Tanaka K Sugimachi 2001 Clinical significance of vascular endothelial growth factor-C (VEGF-C) in breast cancer Breast Cancer Res Treat 66 159 164 1:STN:280:DC%2BD3MzotVWltw%3D%3D 10.1023/A:1010692132669 11437102
2. K Heer H Kumar J Read J Fox J Monson M Kerin 2001 Serum vascular endothelial growth factor in breast cancer: Its relation with cancer type and estrogen receptor status Clin Cancer Res 7 3491 3494 1:CAS:528: DC%2BD3MXptFais7o%3D 11705867
3. A Mitsuhashi K Suzuka K Yamazawa H Matsui K Seki S Sekiya 2005 Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as a tumor markers in patients with cervical carcinoma Cancer 103 724 730 1:CAS:528: DC%2BD2MXit1Ggsrw%3D 10.1002/cncr.20819 15637689
4. J Homer K Anyanwu S Ell J Greenman N Stafford 1999 Serum vascular endothelial growth factor in patients with head and neck squamous cell carcinoma Clin Otolaryngol 24 426 430 1:STN:280:DC%2BD3c%2FhtVKgtQ%3D%3D 10.1046/j.1365-2273.1999.00282.x 10542924
5. L Hefler R Zeillinger C Grimm A Sood W Cheng A Gadducci CB Tempfer A Reinthaller 2006 Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer Gynecol Oncol 103 512 517 1:CAS:528:DC%2BD28XhtFegur7J 10.1016/j.ygyno.2006.03.058 16750560
6. F Gonzalez A Quesada I Sevilla F Baca M Medina J Amores JM Diaz F Rius-Diaz E Marques E Alba 2007 Prognostic value of serum angiogenic activity in colorectal cancer patients J Cell Mol Med 11 120 128 1:CAS:528: DC%2BD2sXlvFCltrs%3D 10.1111/j.1582-4934.2007.00005.x 17367506
7. F De Vita M Orditura E Lieto S Infusino F Morgillo E Martinelli P Castellano C Romano F Ciardiello G Catalano C Pignatelli G Galizia 2004 Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma Cancer 100 270 278 10.1002/cncr.11911 14716760
8. T Wang M Deng W Qiu W Dong 2007 Association of serum vascular endothelial growth factor -C and lymphatic vessel density with lymph node metastasis and prognosis of patients with gastric cancer World J Gastroenterol 13 1794 1798 1:CAS:528:DC%2BD2sXmtV2lu7c%3D 17465468
9. M Tamura Y Ohta 2003 Serum vascular endothelial growth factor -C level in patients with primary nonsmall cell lung carcinoma Cancer 98 1217 1222 1:CAS:528:DC%2BD3sXnvFOhsbo%3D 10.1002/cncr.11529 12973845
10. H Bando H Weich M Brokelmann S Horiguchi N Funata T Ogawa M Toi 2005 Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer Br J Cancer 92 553 561 1:CAS:528: DC%2BD2MXhtFWntL0%3D 15668703
11. J Foekens H Peters N Grabenchtchikov M Look M Meijer-van Gelder A Geurts-Moespot TH van der Kwast CG Sweep JG Klijn 2001 High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in breast cancer Cancer Res 61 5407 541 1:CAS:528:DC%2BD3MXnsVCru7o%3D 11454684
12. A Granato G Frassineti N Giovannini M Ballardini O Nanni R Maltoni D Amadori A Volpi 2006 Do serum angiogenic growth factors provide additional information to that of conventional markers in monitoring the course of metastatic breast cancer? Tumor Biol 27 302 308 1:CAS:528:DC%2BD28XhtFaks7rM 10.1159/000096072
13. R development Core Team: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0 (2008) URL http://www.R-project.org
14. D Konukoglu M Turhan V Celik H Turna 2007 Relation of serum vascular endothelial growth factor as an angiogenesis biomarker with nitric oxide & urokinase-type plasminogen activator in breast cancer patients Indian J Med Res 125 747 751 1:CAS:528:DC%2BD2sXhtFWqtrzK 17704550
15. J Adams P Carder S Downey M Forbes K MacLennan V Allgar S Kaufman S Hallam R Bicknell JJ Walker F Cairnduff PJ Selby TJ Perren M Lansdown RE Banks 2000 Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen Cancer Res 60 2898 2905 1:CAS:528:DC%2BD3cXjvFOltr8%3D 10850435
16. S Mathur R Mathur E Gray D Lane P Underwood M Kohler WT Creasman 2005 Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-B Gynecol Oncol 98 467 483 1:CAS:528:DC%2BD2MXosVClt7o%3D 10.1016/j.ygyno.2005.05.003 15982726
17. M Tamura M Oda I Matsumoto Y Tsunezuka K Kawakami Y Ohta G Watanabe 2004 The combination assai with circulating vascular endothelial growth factor (VEGF)-C, Matrix Metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer Ann Surg Oncol 11 928 933 10.1245/ASO.2004.01.013 15383417
18. B Linderholm B Tavelin K Grankvist R Henriksson 1998 Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma J Clin Oncol 16 3121 3128 1:CAS:528:DyaK1cXmtFSlsb4%3D 9738584
19. L Ryden M Stendahl H Jonsson S Emdin N Bengtsson G Landberg 2005 Tumor specific VEGF-A and VEGFR2 in postmenopausal breast cancer patients with long term folllow up: implication of link between VEGF pathway and tamoxifen response Breast Cancer Res Treat 10 135 143 10.1007/s10549-004-1655-7
20. L Ryden K Jirstrom P Bendahl M Ferno B Nordenskjold O Stal S Thorstenson PE Jönsson G Landberg 2005 Tumor specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer J Clin Oncol 23 4695 4704 1:CAS:528:DC%2BD2MXotFars78%3D 10.1200/JCO.2005.08.126 16034044
21. S Svensson K Jirstrom L Ryden G Roos S Emdin M Ostrowski G Landberg 2005 ERK phosphorylation is linked to VEGFR2 expression and Ets-2 pphosphorylation in breast cancer and is assocoated with tamoxifen resistance and small tumors with good prognosis Oncogene 24 4370 4379 1:CAS:528:DC%2BD2MXlsVWmt74%3D 10.1038/sj.onc.1208626 15806151
22. K Werther I Christensen H Nielsen 2002 Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets Scand J Clin Lab Invest 62 343 350 1:CAS:528:DC%2BD38XosFaku7s%3D 10.1080/00365510260296492 12387579
23. C Kut F Gabhann A Popel 2007 Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer Br J Cancer 97 978 985 1:CAS:528: DC%2BD2sXhtFSnurfE 10.1038/sj.bjc.6603923 17912242
24. Y Kusumanto W Dam G Hospers C Meijer N Mulder 2003 Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor Angiogenesis 6 283 287 1:CAS:528:DC%2BD2cXktlykt7g%3D 10.1023/B:AGEN.0000029415.62384.ba 15166496
25. W Yang K Klos Y Yang T Smith D Shi D Yu 2002 ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human breast carcinoma Cancer 94 2855 2861 1:CAS:528: DC%2BD38XkvVGlt74%3D 10.1002/cncr.10553 12115372